HomeProceduresCorneal Collagen Cross-Linking (CXL)

Cornea

Corneal Collagen Cross-Linking (CXL)

A riboflavin and UV light treatment that strengthens the cornea and stops keratoconus progression in about 95% of cases. Outpatient, no incisions.

Corneal Collagen Cross-Linking (CXL)

What Is Corneal Cross-Linking?

Corneal cross-linking (CXL, short for corneal collagen cross-linking) is a treatment that strengthens the cornea’s structure to stop the progression of keratoconus and other corneal ectasias. It’s the first line of treatment for stopping the disease when it’s caught early.

The procedure combines two elements: riboflavin (vitamin B2) drops and ultraviolet A (UV-A) light. The riboflavin saturates the cornea, and when it’s activated by the UV light, it forms new chemical bonds between the collagen fibers. These bonds act like bridges that stiffen and stabilize the cornea, halting its progressive deformation.

Why Timing Matters So Much

Cross-linking stops progression, it doesn’t reverse damage that’s already been done. This distinction is key:

  • Applied early, it preserves the best possible vision and often avoids the need for a corneal transplant down the road
  • Applied late, once the cornea is already badly deformed, it stops the progression, but the vision already lost doesn’t come back

That’s why, once keratoconus is confirmed to be progressing, especially in teens and young adults, where it tends to advance faster, cross-linking is recommended without delay.

Clinical Indications

Cross-linking is appropriate for patients with:

  • Progressive keratoconus documented by corneal topography
  • Corneal ectasia after refractive surgery (a rare complication of LASIK)
  • Pellucid marginal degeneration and other primary ectasias
  • Sufficient corneal thickness for the treatment to be safe (confirmed by pachymetry)

Contraindications

Cross-linking isn’t recommended when:

  • The cornea is too thin for the standard protocol (variants exist for some cases)
  • There’s significant central corneal scarring
  • There’s an active eye infection
  • There’s a history of poor corneal healing

Step-by-Step Procedure

  1. Pre-treatment evaluation: Pentacam corneal topography, pachymetry, and specular microscopy to confirm the indication and safe thickness.
  2. Day of the procedure: topical anesthesia with drops. The patient reclines comfortably.
  3. Surface preparation: in the standard technique (epithelium-off), the corneal epithelium is gently removed so the riboflavin can penetrate better.
  4. Riboflavin application: riboflavin drops are instilled for several minutes until they saturate the cornea.
  5. UV-A irradiation: ultraviolet light is applied for a controlled amount of time, activating the riboflavin and forming the new collagen bonds.
  6. Bandage contact lens: a bandage contact lens is placed to protect the cornea while the epithelium regenerates, along with antibiotic and anti-inflammatory drops.

The full procedure takes 60 to 90 minutes.

Recovery and Aftercare

For the first 2 to 3 days, while the epithelium regenerates, you may feel:

  • Discomfort, burning, or a foreign body sensation
  • Tearing and light sensitivity
  • Temporary blurry vision

These symptoms are expected and ease as the surface heals. The bandage lens is removed at a follow-up visit, usually between day 3 and 5, and you’ll continue using drops as directed.

Visual recovery:

  • Vision may fluctuate over the first few weeks
  • The cornea keeps remodeling and stabilizing over the following months
  • Follow-up topography confirms that the progression has stopped

Why Choose Centro Láser for Corneal Cross-Linking

Centro Láser has a cornea department with four fellowship-trained subspecialists and precision diagnostics. Before cross-linking, we run a complete evaluation with Pentacam topography, pachymetry, and specular microscopy to confirm the treatment is safe and well-timed for your case. When appropriate, we combine it with intracorneal ring segments to not only stop the keratoconus but also improve vision, all within the same center.

What you should know
about Corneal Collagen Cross-Linking (CXL)

It's a treatment that strengthens the cornea's structure to stop keratoconus progression. It combines riboflavin (vitamin B2) drops with ultraviolet (UV-A) light: the riboflavin activates under the light and forms new bonds between the corneal collagen fibers, essentially welding the cornea to make it stiffer and more stable. It's outpatient and doesn't require any incisions.

Yes. Cross-linking has been shown to stop keratoconus progression in about 95% of cases. It's important to understand that its goal is to halt the disease, not improve vision you've already lost. That's why timing matters so much: the sooner the progression is stopped, the better your vision holds up long term. Afterward, it can be combined with rings or contact lenses to improve visual quality.

As soon as keratoconus is confirmed to be progressing, especially in younger patients, where the disease tends to advance faster. The typical warning sign is a rapid change in your prescription (particularly astigmatism) or documented worsening on corneal topography. If your cornea is already very thin, standard cross-linking may not be safe, and your specialist will evaluate variants or alternatives.

Not during the procedure itself, since topical anesthesia (drops) is used. In the most common technique, the epithelium (the surface layer) is removed, so for the first 2-3 days you may feel discomfort, burning, a foreign body sensation, and light sensitivity, similar to what happens after surface ablation. A bandage contact lens is placed and drops are prescribed for comfort. The discomfort eases as the epithelium regenerates.

Cross-linking is a safe, well-established procedure. Possible risks are uncommon: infection (minimized with an aseptic protocol and antibiotics), delayed epithelial healing, temporary corneal haze that usually clears up over time, and rarely, an insufficient response that requires repeating the treatment. Your specialist checks your corneal thickness beforehand to confirm the treatment is safe for you.

Yes, that is very common. Cross-linking stabilizes the cornea, and once it is stable, it can be combined with intracorneal ring segments to improve corneal curvature and vision, with specialty contact lenses (rigid or scleral), or later with refractive surgery if the cornea remains stable. Your specialist determines the exact sequence based on your case.

Our specialists
in Corneal Collagen Cross-Linking (CXL)

Are you a candidate for Corneal Collagen Cross-Linking (CXL)?

Book your evaluation with our specialists.